You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

METOPROLOL TARTRATE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Metoprolol Tartrate patents expire, and when can generic versions of Metoprolol Tartrate launch?

Metoprolol Tartrate is a drug marketed by Am Regent, Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hikma Farmaceutica, Hospira, Luitpold, Sandoz, Steriscience, Watson Labs, Alembic Pharms Ltd, Apothecon, Aurobindo Pharma, Chartwell Rx, Heritage Pharma, Ipca Labs Ltd, Mylan, Norvium Bioscience, Purepac Pharm, Renata, Rubicon, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Youngtech Pharms Inc, Zydus Pharms, Alembic, and Sun Pharm Inds. and is included in thirty-six NDAs.

The generic ingredient in METOPROLOL TARTRATE is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for METOPROLOL TARTRATE?
What are the global sales for METOPROLOL TARTRATE?
What is Average Wholesale Price for METOPROLOL TARTRATE?

Summary for METOPROLOL TARTRATE

US Patents:	0
Applicants:	30
NDAs:	36
Finished Product Suppliers / Packagers:	54
Raw Ingredient (Bulk) Api Vendors:	109
Clinical Trials:	25
Patent Applications:	1,071
Drug Prices:	Drug price information for METOPROLOL TARTRATE
Drug Sales Revenues:	Drug sales revenues for METOPROLOL TARTRATE
DailyMed Link:	METOPROLOL TARTRATE at DailyMed

Drug patent expirations by year for METOPROLOL TARTRATE

Drug Prices for METOPROLOL TARTRATE

Recent Clinical Trials for METOPROLOL TARTRATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Consorcio Centro de Investigación Biomédica en Red (CIBER)	Phase 3
Instituto de Salud Carlos III	Phase 3
European Commission	Phase 3

See all METOPROLOL TARTRATE clinical trials

Pharmacology for METOPROLOL TARTRATE

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for METOPROLOL TARTRATE

C07AB	Beta blocking agents, selective
C07A	BETA BLOCKING AGENTS
C07	BETA BLOCKING AGENTS
C	Cardiovascular system

US Patents and Regulatory Information for METOPROLOL TARTRATE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm Inds	METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; metoprolol tartrate	TABLET;ORAL	090654-002	Jan 19, 2012		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Renata	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	074453-002	Apr 27, 1995	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	076704-004	Mar 18, 2015	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sun Pharm Inds Inc	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	074644-002	Dec 10, 1996	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Youngtech Pharms Inc	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	208955-002	Feb 5, 2020	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Rubicon	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	200981-005	Aug 21, 2019	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sun Pharm Industries	METOPROLOL TARTRATE	metoprolol tartrate	TABLET;ORAL	073654-002	Jul 15, 2009		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.